4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
31.86
28-March-24 15:59:55
15 minutes delayed
Stocks
-4.01
-11.18%
Today's range
30.25 - 34.20
ISIN
N/A
Source
NASDAQ
-
4DMT to Participate in Upcoming Investor Conferences
07 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
07 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results and Operational Highlights
09 Aug 2023 16:05:00 By Nasdaq GlobeNewswire
-
29 Jul 2023 12:00:00 By Nasdaq GlobeNewswire
-
17 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
07 Jun 2023 16:10:17 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
01 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
24 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
11 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
10 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
09 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
08 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
04 May 2023 21:04:59 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
04 May 2023 16:08:59 By Nasdaq GlobeNewswire
-
27 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
24 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
13 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Reports Full Year 2022 Financial Results and Operational Highlights
15 Mar 2023 16:05:01 By Nasdaq GlobeNewswire
-
22 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
16 Feb 2023 16:05:00 By Nasdaq GlobeNewswire